These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 20552235)

  • 1. Motor neuron-immune interactions: the vicious circle of ALS.
    Barbeito AG; Mesci P; Boillée S
    J Neural Transm (Vienna); 2010 Aug; 117(8):981-1000. PubMed ID: 20552235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immunity in amyotrophic lateral sclerosis.
    Moisse K; Strong MJ
    Biochim Biophys Acta; 2006; 1762(11-12):1083-93. PubMed ID: 16624536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinergic implication in amyotrophic lateral sclerosis-from pathological mechanisms to therapeutic perspectives.
    Cieślak M; Roszek K; Wujak M
    Purinergic Signal; 2019 Mar; 15(1):1-15. PubMed ID: 30430356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival.
    Chiot A; Zaïdi S; Iltis C; Ribon M; Berriat F; Schiaffino L; Jolly A; de la Grange P; Mallat M; Bohl D; Millecamps S; Seilhean D; Lobsiger CS; Boillée S
    Nat Neurosci; 2020 Nov; 23(11):1339-1351. PubMed ID: 33077946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune reactivity in a mouse model of familial ALS correlates with disease progression.
    Alexianu ME; Kozovska M; Appel SH
    Neurology; 2001 Oct; 57(7):1282-9. PubMed ID: 11591849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease.
    Philips T; Robberecht W
    Lancet Neurol; 2011 Mar; 10(3):253-63. PubMed ID: 21349440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis.
    Weydt P; Möller T
    Neuroreport; 2005 Apr; 16(6):527-31. PubMed ID: 15812300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.
    Zhao W; Beers DR; Appel SH
    J Neuroimmune Pharmacol; 2013 Sep; 8(4):888-99. PubMed ID: 23881705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes.
    Gorter RP; Stephenson J; Nutma E; Anink J; de Jonge JC; Baron W; Jahreiβ MC; Belien JAM; van Noort JM; Mijnsbergen C; Aronica E; Amor S
    Neuropathol Appl Neurobiol; 2019 Aug; 45(5):459-475. PubMed ID: 30346063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
    Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-17 and Th17 Lymphocytes Directly Impair Motoneuron Survival of Wildtype and FUS-ALS Mutant Human iPSCs.
    Jin M; Akgün K; Ziemssen T; Kipp M; Günther R; Hermann A
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-Microglia Interactions in Motor Neuron Degeneration. The Inflammatory Hypothesis in Amyotrophic Lateral Sclerosis Revisited.
    Rodríguez MJ; Mahy N
    Curr Med Chem; 2016; 23(42):4753-4772. PubMed ID: 27881068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation.
    Sta M; Sylva-Steenland RM; Casula M; de Jong JM; Troost D; Aronica E; Baas F
    Neurobiol Dis; 2011 Jun; 42(3):211-20. PubMed ID: 21220013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant SOD1 prevents normal functional recovery through enhanced glial activation and loss of motor neuron innervation after peripheral nerve injury.
    Schram S; Chuang D; Schmidt G; Piponov H; Helder C; Kerns J; Gonzalez M; Song F; Loeb JA
    Neurobiol Dis; 2019 Apr; 124():469-478. PubMed ID: 30594811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis.
    Garofalo S; Cocozza G; Porzia A; Inghilleri M; Raspa M; Scavizzi F; Aronica E; Bernardini G; Peng L; Ransohoff RM; Santoni A; Limatola C
    Nat Commun; 2020 Apr; 11(1):1773. PubMed ID: 32286313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
    Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP
    J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis.
    El Oussini H; Bayer H; Scekic-Zahirovic J; Vercruysse P; Sinniger J; Dirrig-Grosch S; Dieterlé S; Echaniz-Laguna A; Larmet Y; Müller K; Weishaupt JH; Thal DR; van Rheenen W; van Eijk K; Lawson R; Monassier L; Maroteaux L; Roumier A; Wong PC; van den Berg LH; Ludolph AC; Veldink JH; Witting A; Dupuis L
    Acta Neuropathol; 2016 Mar; 131(3):465-80. PubMed ID: 26744351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.